Alternative digestion approaches improve histone modification mapping by mass spectrometry in clinical samples.

epigenetic mark histone posttranslational modifications mass spectrometry proteomics reversed-phase chromatography

Journal

Proteomics. Clinical applications
ISSN: 1862-8354
Titre abrégé: Proteomics Clin Appl
Pays: Germany
ID NLM: 101298608

Informations de publication

Date de publication:
01 2019
Historique:
received: 29 05 2018
revised: 03 10 2018
pubmed: 25 11 2018
medline: 4 4 2019
entrez: 25 11 2018
Statut: ppublish

Résumé

Profiling histone posttranslational modifications (PTMs) in clinical samples holds great potential for the identification of epigenetic biomarkers and the discovery of novel epigenetic targets. MS-based approaches to analyze histone PTMs in clinical samples usually rely on SDS-PAGE separation following histone enrichment in order to eliminate detergents and further isolate histones. However, this limits the digestions options and hence the modification coverage. The aim of this study is the implementation of a procedure involving acetone protein precipitation followed by histone enrichment through a C18 StageTip column to obtain histone preparations suitable for various in-solution digestion protocols. Among them, the Arg-C digestion, which allows profiling histone H4 modifications, and the Prop-PIC method, which improves the detection of short and hydrophilic peptides, are tested. This approach is validated on different types of samples, including formalin-fixed paraffin-embedded pathology tissues, and employed to profile histone H4 modifications in cancer samples and normal tissues, identifying previously reported differences, as well as novel ones. This protocol widens the number of applications available in the toolbox of clinical epigenomics, allowing the investigation of a larger spectrum of histone marks in patient samples.

Identifiants

pubmed: 30471193
doi: 10.1002/prca.201700166
doi:

Substances chimiques

Histones 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1700166

Subventions

Organisme : Italian Association for Cancer Research
ID : 15741
Pays : International
Organisme : Italian Ministry of Health
ID : GR-2011-02347880
Pays : International
Organisme : CNR-EPIGEN
Pays : International
Organisme : Italian Ministry of Health
ID : GR-2016-02361522
Pays : International
Organisme : Fondazione IEO-CCM
Pays : International

Informations de copyright

© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Camilla Restellini (C)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Alessandro Cuomo (A)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Michela Lupia (M)

Unit of Gynecological Oncology Research, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Marco Giordano (M)

Unit of Gynecological Oncology Research, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Tiziana Bonaldi (T)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Roberta Noberini (R)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH